Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Current Ratio
since 2019

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Shockwave Medical Inc., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 US$ in thousands


Current Assets
The current assets exhibit a consistent upward trend over the five-year period. Starting at 216,697 thousand US dollars in 2019, the figure increased moderately to 246,300 thousand in 2020 and further to 285,902 thousand in 2021. A substantial jump occurred in 2022, with current assets rising to 459,263 thousand and a more pronounced surge in 2023, reaching 1,225,260 thousand. This growth trajectory indicates a strengthening liquidity position and possibly accumulation of cash, receivables, or inventory.
Current Liabilities
Current liabilities have also increased over the same period but at a much slower rate compared to current assets. Beginning at 24,008 thousand US dollars in 2019, liabilities grew slightly to 25,581 thousand in 2020, then nearly doubled to 51,628 thousand in 2021. Subsequent increases were more modest with 63,374 thousand in 2022 and 104,205 thousand in 2023. Although liabilities are rising, the pace remains controlled relative to assets.
Current Ratio
The current ratio, calculated as current assets divided by current liabilities, shows notable fluctuations but an overall robust liquidity profile. The ratio started very high at 9.03 in 2019, increased to 9.63 in 2020, then declined sharply to 5.54 in 2021. A recovery is evident with the ratio climbing to 7.25 in 2022 and reaching a peak of 11.76 in 2023. These values consistently exceed the conventional benchmark of 1, suggesting strong short-term financial health. The dip in 2021 could indicate a relative increase in liabilities or a slower growth in assets during that year, while the subsequent rebound points to improved asset liquidity or liability management.
Summary
Overall, the analysis indicates that the company has significantly improved its liquidity position over the five-year period, especially in the last two years. The sharp increases in current assets, outpacing the growth in current liabilities, have led to a strengthened current ratio, culminating in an exceptionally high ratio of 11.76 in 2023. This suggests ample short-term resources to cover obligations. The temporary dip in the current ratio during 2021 merits attention as it reflects a less favorable but still strong liquidity status. The upward trends in liquidity measures imply favorable working capital management and a potentially lower liquidity risk.

Comparison to Competitors

Shockwave Medical Inc., current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Sector (Health Care Equipment & Services)

Shockwave Medical Inc., current ratio, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Industry (Health Care)

Shockwave Medical Inc., current ratio, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).